AMKR vs MTSI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMKR exhibits exceptional fundamental health with a Piotroski F-Score of 8/9 and a strong liquidity profile (Current Ratio 2.27). However, the stock is currently experiencing a severe valuation disconnect, trading at $78.11—significantly above its Graham Number ($24.70), Intrinsic Value ($44.25), and the average analyst target ($57.25). While explosive earnings growth (61% YoY) and a low PEG ratio (0.76) justify a premium, the massive 1-year price surge of 354% combined with bearish insider selling suggests the stock is overextended. The outlook is a tug-of-war between elite operational performance and an unsustainable valuation multiple.
MTSI exhibits strong operational health with a Piotroski F-Score of 7/9 and a robust liquidity profile (Current Ratio 3.96). However, the company is severely overvalued, trading at a massive premium to its Graham Number ($30.02) and Intrinsic Value ($15.54), with a trailing P/E of 118.88. While revenue growth is solid at 24.5% and earnings beats are consistent over 25 quarters, heavy insider selling ($184.61M) and a bearish technical trend suggest a potential peak. The stock is currently a high-growth play where the market has priced in perfection, leaving little margin for error.
Compare Another Pair
Related Comparisons
AMKR vs MTSI: Head-to-Head Comparison
This page compares Amkor Technology, Inc. (AMKR) and MACOM Technology Solutions Holdings, Inc. (MTSI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.